Everett E. Vokes to Vision Disorders
This is a "connection" page, showing publications Everett E. Vokes has written about Vision Disorders.
Connection Strength
0.154
-
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor. Cancer. 2018 05 15; 124(10):2174-2183.
Score: 0.154